144 related articles for article (PubMed ID: 15454294)
1. Surfactant vesicle-mediated delivery of DNA vaccines via the subcutaneous route.
Perrie Y; Barralet JE; McNeil S; Vangala A
Int J Pharm; 2004 Oct; 284(1-2):31-41. PubMed ID: 15454294
[TBL] [Abstract][Full Text] [Related]
2. Liposome-mediated DNA immunisation via the subcutaneous route.
Perrie Y; McNeil S; Vangala A
J Drug Target; 2003; 11(8-10):555-63. PubMed ID: 15203925
[TBL] [Abstract][Full Text] [Related]
3. Liposome-mediated DNA vaccination: the effect of vesicle composition.
Perrie Y; Frederik PM; Gregoriadis G
Vaccine; 2001 Apr; 19(23-24):3301-10. PubMed ID: 11312029
[TBL] [Abstract][Full Text] [Related]
4. Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen.
Vangala A; Bramwell VW; McNeil S; Christensen D; Agger EM; Perrie Y
J Control Release; 2007 May; 119(1):102-10. PubMed ID: 17331610
[TBL] [Abstract][Full Text] [Related]
5. Liposome (Lipodine)-mediated DNA vaccination by the oral route.
Perrie Y; Obrenovic M; McCarthy D; Gregoriadis G
J Liposome Res; 2002; 12(1-2):185-97. PubMed ID: 12604053
[TBL] [Abstract][Full Text] [Related]
6. Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines.
Carstens MG; Camps MG; Henriksen-Lacey M; Franken K; Ottenhoff TH; Perrie Y; Bouwstra JA; Ossendorp F; Jiskoot W
Vaccine; 2011 Jun; 29(29-30):4761-70. PubMed ID: 21565240
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study.
Gupta PN; Mishra V; Rawat A; Dubey P; Mahor S; Jain S; Chatterji DP; Vyas SP
Int J Pharm; 2005 Apr; 293(1-2):73-82. PubMed ID: 15778046
[TBL] [Abstract][Full Text] [Related]
8. Preparation of plasmid DNA-containing liposomes using a high-pressure homogenization--extrusion technique.
Pupo E; Padrón A; Santana E; Sotolongo J; Quintana D; Dueñas S; Duarte C; de la Rosa MC; Hardy E
J Control Release; 2005 May; 104(2):379-96. PubMed ID: 15907587
[TBL] [Abstract][Full Text] [Related]
9. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B.
Vyas SP; Singh RP; Jain S; Mishra V; Mahor S; Singh P; Gupta PN; Rawat A; Dubey P
Int J Pharm; 2005 May; 296(1-2):80-6. PubMed ID: 15885458
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice.
Vangala A; Kirby D; Rosenkrands I; Agger EM; Andersen P; Perrie Y
J Pharm Pharmacol; 2006 Jun; 58(6):787-99. PubMed ID: 16734980
[TBL] [Abstract][Full Text] [Related]
11. Surface modified liposomes for nasal delivery of DNA vaccine.
Khatri K; Goyal AK; Gupta PN; Mishra N; Mehta A; Vyas SP
Vaccine; 2008 Apr; 26(18):2225-33. PubMed ID: 18396362
[TBL] [Abstract][Full Text] [Related]
12. Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection.
Mann JF; Shakir E; Carter KC; Mullen AB; Alexander J; Ferro VA
Vaccine; 2009 Jun; 27(27):3643-9. PubMed ID: 19464545
[TBL] [Abstract][Full Text] [Related]
13. Chemical adjuvants for plasmid DNA vaccines.
Greenland JR; Letvin NL
Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
[TBL] [Abstract][Full Text] [Related]
14. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration.
Hattori Y; Kawakami S; Lu Y; Nakamura K; Yamashita F; Hashida M
J Gene Med; 2006 Jul; 8(7):824-34. PubMed ID: 16625665
[TBL] [Abstract][Full Text] [Related]
15. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
16. Cationic transfersomes based topical genetic vaccine against hepatitis B.
Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
[TBL] [Abstract][Full Text] [Related]
17. Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity.
van den Berg JH; Oosterhuis K; Hennink WE; Storm G; van der Aa LJ; Engbersen JF; Haanen JB; Beijnen JH; Schumacher TN; Nuijen B
J Control Release; 2010 Jan; 141(2):234-40. PubMed ID: 19751778
[TBL] [Abstract][Full Text] [Related]
18. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.
Jain S; Singh P; Mishra V; Vyas SP
Immunol Lett; 2005 Oct; 101(1):41-9. PubMed ID: 15869802
[TBL] [Abstract][Full Text] [Related]
19. Vaccine entrapment in liposomes.
Gregoriadis G; McCormack B; Obrenovic M; Saffie R; Zadi B; Perrie Y
Methods; 1999 Sep; 19(1):156-62. PubMed ID: 10525452
[TBL] [Abstract][Full Text] [Related]
20. In vivo cutaneous interferon-gamma gene delivery using novel dicationic (gemini) surfactant-plasmid complexes.
Badea I; Verrall R; Baca-Estrada M; Tikoo S; Rosenberg A; Kumar P; Foldvari M
J Gene Med; 2005 Sep; 7(9):1200-14. PubMed ID: 15895387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
